From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders [Von der identifizierung neurofunktioneller systeme zur individualisierung der therapie schizophrener störungen]

被引:0
|
作者
Gruber O. [1 ,2 ]
Falkai P. [1 ]
机构
[1] Zentrum fur Translationale Forschung in Systemischen Neurowissenschaften und Klinischer Psychiatrie, Klinik für Psychiatrie und Psychotherapie, Georg-August-Universität, Göttingen
[2] Zentrum fur Translationale Forschung in Systemischen Neurowissenschaften und Klinischer Psychiatrie, Klinik für Psychiatrie und Psychotherapie, Georg-August-Universität, 37075 Göttingen
关键词
Differential Pharmacotherapy with Antipsychotics; Endophenotype; Experimental Neuropsychology; FMRI; Translational Research;
D O I
10.1007/s00115-008-2615-y
中图分类号
学科分类号
摘要
This article outlines the role of systemic neuroscience in research of the pathogenesis and pathophysiology of schizophrenic and other psychotic disorders and in the development of diagnostic and prognostic tools to permit individualized and optimized pharmacotherapy for these disorders. Based on preclinical and clinical studies of the physiology and pathophysiology of human working memory, it is possible to establish intermediate neurofunctional phenotypes that, given the current lack of identified pathological substrates, may serve as biological markers for diagnosing factual disease entities. In this way the use of functional neuroimaging techniques may allow the identification of subtypes of the psychotic disorders that so far are uniformly diagnosed according to current psychiatric classification systems. This may permit more precise diagnosis and a specification and optimization of pharmacotherapy. © 2009 Springer Medizin Verlag.
引用
收藏
页码:12 / 21
页数:9
相关论文
共 5 条
  • [1] From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders
    Gruber, O.
    Falkai, P.
    NERVENARZT, 2009, 80 (01): : 12 - +
  • [2] From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders
    Falkai, P.
    EUROPEAN PSYCHIATRY, 2017, 41 : S52 - S52
  • [3] Neues zur symptomatischen MS-Therapie: Teil 4 – Störungen der Sexualfunktion und der AugenbewegungenNew aspects of symptomatic MS treatment: Part 4—sexual dysfunction and eye movement disorders
    T. Henze
    W. Feneberg
    P. Flachenecker
    D. Seidel
    H. Albrecht
    M. Starck
    S. G. Meuth
    Der Nervenarzt, 2018, 89 (2) : 193 - 197
  • [4] Autismus-Spektrum-Störungen: von der Früherfassung zu Intervention und BegleitungAutism spectrum disorders: from early identification to intervention and case management
    Johannes Hofer
    Johannes Fellinger
    Monatsschrift Kinderheilkunde, 2022, 170 : 443 - 452
  • [5] New concepts for ICD-classification of common mental disorders from the perspective of general medical practice [Neue Begriffe zur ICD-Klassifizierung von psychischen Störungen aus der Sicht der Allgemeinmedizin]
    Spiegel W.
    Goldberg D.
    Princz C.
    Fellinger P.
    Wiener Medizinische Wochenschrift, 2015, 165 (15-16) : 310 - 314